See more : Neurogenesis, Inc. (NEUN) Income Statement Analysis – Financial Results
Complete financial analysis of Churchill Capital Corp VII (CVII-WT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Churchill Capital Corp VII, a leading company in the Shell Companies industry within the Financial Services sector.
- BVZ Holding AG (BVZHF) Income Statement Analysis – Financial Results
- Chongqing Shunbo Aluminum Co.,Ltd. (002996.SZ) Income Statement Analysis – Financial Results
- The Saudi Arabian Amiantit Company (2160.SR) Income Statement Analysis – Financial Results
- Auckland International Airport Limited (AIA.AX) Income Statement Analysis – Financial Results
- Methanol Chemicals Company (2001.SR) Income Statement Analysis – Financial Results
Churchill Capital Corp VII (CVII-WT)
Industry: Shell Companies
Sector: Financial Services
About Churchill Capital Corp VII
Churchill Capital Corp VII, a blank check company, focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 6.60M | 2.32M | 2.38M | 0.00 |
| Gross Profit | -6.60M | -2.32M | -2.38M | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 6.60M | 2.32M | 2.38M | 4.00K |
| Other Expenses | 0.00 | 2.32M | 2.38M | 0.00 |
| Operating Expenses | 10.82M | 2.32M | 2.38M | 4.00K |
| Cost & Expenses | 10.82M | 2.32M | 2.38M | 4.00K |
| Interest Income | 0.00 | 20.05M | 324.38K | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 6.60M | 2.32M | 2.38M | 4.00K |
| EBITDA | 35.99M | -59.80M | -121.80K | 4.00 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -6.60M | -2.32M | -2.38M | -4.00K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 35.99M | 77.54M | -1.93M | 0.00 |
| Income Before Tax | 29.39M | 75.22M | -4.30M | -4.00K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 13.00M | 4.17M | 24.24K | -996.00 |
| Net Income | 16.39M | 71.05M | -4.33M | -4.00K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.13 | 0.41 | -0.03 | 0.00 |
| EPS Diluted | 0.13 | 0.41 | -0.03 | 0.00 |
| Weighted Avg Shares Out | 122.40M | 172.50M | 172.50M | 30.00M |
| Weighted Avg Shares Out (Dil) | 122.40M | 172.50M | 172.50M | 30.00M |
Source: https://incomestatements.info
Category: Stock Reports